نتایج جستجو برای: tp53 mutation and expression

تعداد نتایج: 16973495  

Journal: :Annals of hepatology 2005
Mauricio Moreno Fernando Pimentel Adi F Gazdar Ignacio I Wistuba Juan F Miquel

BACKGROUND Gallbladder carcinoma (GBC) is a frequent neoplasm in Hispanic and native American populations. GBC is preceded by gallstones, chronic cholecystitis and dysplastic changes of the gallbladder epithelium. The knowledge of the molecular events involved in its pathogenesis is scarce. AIMS We investigated the role of TP53 inactivation in the sequential pathogenesis of GBC. METHODS Inv...

Journal: :Cancer research 2009
Henne Holstege Simon A Joosse Conny Th M van Oostrom Petra M Nederlof Annemieke de Vries Jos Jonkers

Approximately half of all hereditary breast cancers are compromised in their DNA repair mechanisms due to loss of BRCA1 or BRCA2 function. Previous research has found a strong correlation between BRCA mutation and TP53 mutation. However, TP53 mutation status is often indirectly assessed by immunohistochemical staining of accumulated p53 protein. We sequenced TP53 exons 2 to 9 in 21 BRCA1-relate...

2014
NAOHIKO IKEGAKI SAKEENAH L. HICKS PAUL L. REGAN JOSHUA JACOBS AMINA S. JUMBO PAYTON LEONHARDT ERIC F. RAPPAPORT XAO X. TANG

Neuroblastoma is a common pediatric solid tumor that exhibits a striking clinical bipolarity: favorable and unfavorable. The survival rate of children with unfavorable neuroblastoma remains low among all childhood cancers. MYCN and MYC play a crucial role in determining the malignancy of unfavorable neuroblastomas, whereas high-level expression of the favorable neuroblastoma genes is associated...

Journal: :Applied sciences 2022

Background: Mutation of p53 is a frequent event, and mutant exhibits low levels acetylation phosphorylation. This study aimed to investigate the effect histone deacetylase (HDAC) inhibitor, 4-hexylresorcinol (4HR), on phosphorylation carcinoma cells its therapeutic effects in xenograft model. Methods: To determine 4HR p53, western blot analysis was performed using YD-9 YD-15 cells. siRNA used e...

Journal: :Journal of Thoracic Oncology 2021

The poly ADP ribose polymerase (PARP) expression is significantly higher in SCLC than normal lung epithelial cells and other histologic subtypes of cancer. In preclinical models, the loss function mutation Cyclin-dependent kinase 12 (CDK12) was related to PARP inhibitor sensitivity (Bajrami et al., 2014). This found 1.7% (Julie 2015). However, little known about clinical implications CDK12 muta...

2015
Mozhgan Rasti Tayebeh Azimi

BACKGROUND Tumour suppressor genes such as TP53, BRCA1 and RAD51 are involved in DNA repair and their malfunctions result in genomic instability and cancer. Wild type (WT) TP53 binds to BRCA1and RAD51 in vivo and in vitro. However, mutated TP53 in tumours can interfere with WT TP53 function. We studied how mutation of TP53 in MDA-MB-468 cell line could affect its binding capacity and interfere ...

Journal: :Cancer research 2000
E M Berns J A Foekens R Vossen M P Look P Devilee S C Henzen-Logmans I L van Staveren W L van Putten M Inganäs M E Meijer-van Gelder C Cornelisse C J Claassen H Portengen B Bakker J G Klijn

TP53 has been implicated in regulation of the cell cycle, DNA repair, and apoptosis. We studied, in primary breast tumors through direct cDNA sequencing of exons 2-11, whether TP53 gene mutations can predict response in patients with advanced disease to either first-line tamoxifen therapy (202 patients, of whom 55% responded) or up-front (poly)chemotherapy (41 patients, of whom 46% responded). ...

2011
Olivier Galy Isabelle Chemin Emilie Le Roux Stéphanie Villar Florence Le Calvez-Kelm Myriam Lereau Doriane Gouas Beatriz Vieco Iris Suarez Maria-Cristina Navas Michèle Chevallier Helene Norder Petcharin Srivatanakul Anant Karalak Suleeporn Sangrajrang Christian Trépo Pierre Hainaut

Hepatocellular carcinoma (HCC) may develop according to two major pathways, one involving HBV infection and TP53 mutation and the other characterized by HCV infection and CTNNB1 mutation. We have investigated HBV/HCV infections and TP53/CTNNB1 mutations in 26 HCC patients from Thailand. HBV DNA (genotype B or C) was detected in 19 (73%) of the cases, including 5 occult infections and 3 coinfect...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Magali Olivier Anita Langerød Patrizia Carrieri Jonas Bergh Sigrid Klaar Jorunn Eyfjord Charles Theillet Carmen Rodriguez Rosette Lidereau Ivan Bièche Jennifer Varley Yves Bignon Nancy Uhrhammer Robert Winqvist Arja Jukkola-Vuorinen Dieter Niederacher Shunsuke Kato Chikashi Ishioka Pierre Hainaut Anne-Lise Børresen-Dale

To investigate the clinical value of somatic TP53 mutations in breast cancer, we assembled clinical and molecular data on 1,794 women with primary breast cancer with long-term follow-up and whose tumor has been screened for mutation in exons 5 to 8 of TP53 by gene sequencing. TP53 mutations were more frequent in tumors of ductal and medullar types, aggressive phenotype (high grade, large size, ...

2012
Simona Ognjanovic Ghyslaine Martel Carlos Manivel Magali Olivier Erica Langer Pierre Hainaut

The tumor suppressor gene TP53 is the most commonly mutated gene in human cancer. The reported prevalence of mutations in rhabdomyosarcoma (RMS) varies widely, with recent larger studies suggesting that TP53 mutations in pediatric RMS may be extremely rare. Overexpression of MDM2 also attenuates p53 function. We have performed TP53 mutation/MDM2 amplification analyses in the largest series anal...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید